Literature DB >> 24603524

Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012).

Sigrid Gouma1,2, Jussi Sane3,2, Daphne Gijselaar2, Jeroen Cremer2, Susan Hahné2, Marion Koopmans1,2, Rob van Binnendijk2.   

Abstract

During three seasons of mumps outbreaks in the Netherlands (September 2009-August 2012), 822 mumps cases were laboratory-confirmed at the National Institute for Public Health and the Environment (RIVM). Most patients were vaccinated young adults. Given the protracted endemic circulation, we studied the genetic diversity and changes of mumps virus over a period of 3 years. Phylogenetic analysis of the small hydrophobic (SH) gene (316 bp) was performed on a representative set of 808 specimens that tested positive for mumps via PCR. Additionally, the haemagglutinin/neuraminidase (HN) gene (1749 bp) and fusion (F) gene (1617 bp) were sequenced for a subset of samples (n = 17). Correlations between different sequence types and epidemiological and clinical data were investigated. The outbreaks in the Netherlands were dominated by two SH gene sequence types within genotype G, termed MuVs/Delft.NLD/03.10 (variant 1) and MuVs/Scheemda.NLD/12.10 (variant 2). Sequence analysis of the HN and F genes indicated that the outbreaks were initiated by separately introduced genetic lineages. The predominance of variant 2 by the end of the first outbreak season could not be explained by any of the epidemiological factors investigated. Orchitis was more frequently reported in males infected with variant 2, irrespective of age and vaccination status. These findings illustrate genetic heterogeneity of an emerging mumps genotype, and raise questions about the mechanisms driving mumps epidemiology and immunity in relation to vaccination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603524     DOI: 10.1099/vir.0.062943-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.

Authors:  James Zengel; Shannon I Phan; Adrian Pickar; Pei Xu; Biao He
Journal:  Vaccine       Date:  2017-06-13       Impact factor: 3.641

2.  Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.

Authors:  Patricia Kaaijk; Sigrid Gouma; Hinke I Hulscher; Wanda G Han; Deborah E Kleijne; Rob S van Binnendijk; Cécile A van Els
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Complete Genome Sequences of Mumps and Measles Virus Isolates from Three States in the United States.

Authors:  Laura C Magaña; Alex Espinosa; Rachel L Marine; Terry Fei Fan Ng; Christina J Castro; Anna M Montmayeur; Jill K Hacker; Samantha Scott; Thomas Whyte; Bettina Bankamp; M Steven Oberste; Paul A Rota
Journal:  Genome Announc       Date:  2017-08-17

4.  Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.

Authors:  Sigrid Gouma; Tessa Vermeire; Steven Van Gucht; Lennart Martens; Veronik Hutse; Jeroen Cremer; Paul A Rota; Geert Leroux-Roels; Marion Koopmans; Rob van Binnendijk; Elien Vandermarliere
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

5.  Visual tools to assess the plausibility of algorithm-identified infectious disease clusters: an application to mumps data from the Netherlands dating from January 2009 to June 2016.

Authors:  Loes Soetens; Jantien A Backer; Susan Hahné; Rob van Binnendijk; Sigrid Gouma; Jacco Wallinga
Journal:  Euro Surveill       Date:  2019-03

Review 6.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

7.  Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection.

Authors:  Josien Lanfermeijer; Marieke M Nühn; Maarten E Emmelot; Martien C M Poelen; Cécile A C M van Els; José A M Borghans; Debbie van Baarle; Patricia Kaaijk; Jelle de Wit
Journal:  Vaccines (Basel)       Date:  2021-12-03

8.  High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China.

Authors:  Xiang Sun; Fenyang Tang; Ying Hu; Xiuying Deng; Zhiguo Wang; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2020-01-24       Impact factor: 3.452

9.  Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

Authors:  Arnaud G L'Huillier; Alireza Eshaghi; C Sarai Racey; Katherene Ogbulafor; Ernesto Lombos; Rachel R Higgins; David C Alexander; Erik Kristjanson; Jocelyn Maregmen; Jonathan B Gubbay; Tony Mazzulli
Journal:  Virol J       Date:  2018-06-05       Impact factor: 4.099

10.  Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016.

Authors:  Lamprini Veneti; Katrine Borgen; Kaja Sverdrup Borge; Kostas Danis; Margrethe Greve-Isdahl; Kirsten Konsmo; Gro Njølstad; Svein Arne Nordbø; Kari Stidal Øystese; Rikard Rykkvin; Eli Sagvik; Øystein Rolandsen Riise
Journal:  Euro Surveill       Date:  2018-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.